Displaying drugs 10301 - 10325 of 10872 in total
NKG2D-ACE2 CAR-NK Cell
These cells are prepared as universal off-the-shelf CAR-NK cells from cord blood with NKG2D-ACE2 proteins engineered as part of the CARs; the cell secretes IL-15 and GM-CSF. Chimeric antigen receptors (CARs) are artificial receptors consisting of an antibody-derived antigen binding domain and transmembrane and signaling domains from T-cell receptor signalling...
Investigational
Matched Description: … inhibiting SARS-Cov-2 infection of type II alveolar epithelial cells. ... as universal off-the-shelf CAR-NK cells from cord blood with NKG2D-ACE2 proteins engineered as part of ... Chimeric antigen receptors (CARs) are artificial receptors consisting of an antibody-derived antigen …
AN-2718
An2718 has been used in trials studying Tinea Pedis.
Investigational
Matched Description: … An2718 has been used in trials studying Tinea Pedis. …
Turofexorate isopropyl
Fxr 450 is under investigation in clinical trial NCT00509756 (Study Evaluating Turofexorate isopropyl in Healthy Japanese Men).
Investigational
Matched Description: … in Healthy Japanese Men). ... Fxr 450 is under investigation in clinical trial NCT00509756 (Study Evaluating Turofexorate isopropyl …
DCFBC F-18
DCFBC F-18 is under investigation in clinical trial NCT02190279 (18F-DCFBC PET/CT in Prostate Cancer).
Investigational
Matched Description: … DCFBC F-18 is under investigation in clinical trial NCT02190279 (18F-DCFBC PET/CT in Prostate Cancer) …
Modotuximab
Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).
Investigational
Matched Description: … in Patients With mCRC). ... Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab …
AZD-9496
AZD-9496 is under investigation in clinical trial NCT02248090 (AZD9496 First Time in Patients Ascending Dose Study).
Investigational
Matched Description: … AZD-9496 is under investigation in clinical trial NCT02248090 (AZD9496 First Time in Patients Ascending …
CDC-801
CDC-801 is under investigation in clinical trial NCT00006097 (Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia).
Investigational
Matched Description: … CDC-801 is under investigation in clinical trial NCT00006097 (Chemotherapy in Treating Patients With …
BI 44370 TA
BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).
Investigational
Matched Description: … BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack …
DU125530
DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder).
Investigational
Matched Iupac: … 2-{4-[4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]butyl}-2,3-dihydro-1lambda6,2-benzothiazole …
Matched Description: … in Major Depressive Disorder). ... DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 …
Matched Description: … in Major Depressive Disorder). ... DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 …
GP2 peptide
GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).
Investigational
Matched Description: … GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients …
Polifeprosan 20
Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).
Investigational
Matched Description: … Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating …
Troplasminogen alfa
Troplasminogen alfa is under investigation in clinical trial NCT00144014 (Safety and Efficacy Study in Acute Ischaemic Stroke).
Investigational
Matched Description: … Troplasminogen alfa is under investigation in clinical trial NCT00144014 (Safety and Efficacy Study in …
OC-459
OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.
Investigational
Matched Description: … OC000459 has been investigated for the treatment of Bronchial Asthma. ... OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. …
Adrabetadex
Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1).
Investigational
Matched Description: … Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous …
Delgocitinib
Delgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema).
Investigational
Matched Description: … Delgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate ... Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in …
VXA-CoV2-1
VXA-CoV2-1 is a non-replicating adenoviral vector-based oral tableted vaccine candidate that expresses a SARS-CoV-2 antigen and dsRNA adjuvant . This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell responses to both...
Investigational
Matched Description: … to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell responses ... to both vaccine antigens of the SARS-CoV-2 nucleocapsid and spike proteins[L30498]. ... This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies …
alpha-D-quinovopyranose
The pyranose form of D-quinovose with an α-configuration at the anomeric position .
Experimental
Matched Description: … The pyranose form of D-quinovose with an α-configuration at the anomeric position . …
Bryostatin 1
Bryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease.
Investigational
Matched Description: … Bryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease. …
Cicletanine
Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial Hypertension.
Investigational
Matched Iupac: … 3-(4-chlorophenyl)-6-methyl-1H,3H-furo[3,4-c]pyridin-7-ol …
Matched Description: … Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial …
Matched Description: … Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial …
CDX-6210
CDX-6210 is a modified version of a leucine decarboxylase enzyme from Planctomycetaceae bacterium.
Investigational
Matched Description: … CDX-6210 is a modified version of a leucine decarboxylase enzyme from _Planctomycetaceae bacterium_. …
PT886
PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47)
Investigational
Matched Description: … PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47) …
Pittsburgh Compound B
Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).
Investigational
Matched Description: … (Microbleeds) in Atypical AD). ... Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities …
Venanprubart
Venanprubart is under investigation in clinical trial NCT05781451 (Anti-btla Agonist Therapy in Subjects With Primary Sjogren's Syndrome).
Investigational
Matched Description: … Venanprubart is under investigation in clinical trial NCT05781451 (Anti-btla Agonist Therapy in Subjects …
Etofylline nicotinate
Etofylline nicotinate, a theophylline derivative, is a drug that causes vasodilation and relaxation of smooth muscle.
Experimental
Matched Iupac: … 2-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)ethyl pyridine-3-carboxylate …
Matched Description: … Etofylline nicotinate, a theophylline derivative, is a drug that causes vasodilation and relaxation of …
Matched Description: … Etofylline nicotinate, a theophylline derivative, is a drug that causes vasodilation and relaxation of …
LB-P8
LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (Leuconostoc citreum).
Investigational
Matched Description: … LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (_Leuconostoc …
Displaying drugs 10301 - 10325 of 10872 in total